US Stocks
/
Sagimet Biosciences Inc. Series A Share Price

Sagimet Biosciences Inc. Series A Share Price

NASDAQ: SGMT | Micro Cap
$9.07
+$0.34 (3.84%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sagimet Biosciences Inc. Series A Stock Performance

Open
$8.94
Prev. Close
$8.73
Circuit Range
N/A
Day Range
$8.47 - $9.09
Year Range
$4.51 - $10.03
Volume
38,476
Average Traded
$8.79

Sagimet Biosciences Inc. Series A Share Price Today

As of 9 August 2026, Sagimet Biosciences Inc. Series A's share price is $9.07. The stock opened at $8.94, compared to its previous close of $8.73. During today's trading session, Sagimet Biosciences Inc. Series A's share price traded between $8.47 and $9.09, with an average price of $8.78. Over the past 52 weeks, the stock has recorded a high of $10.03 and a low of $4.51. In terms of performance, Sagimet Biosciences Inc. Series A's share price has risen by 58.57% over the last six months and is up 21.26% on a year-on-year basis.

Sagimet Biosciences Inc. Series A Share Price Chart

$8.47$9.09
L
Show Current Price
H

Sagimet Biosciences Inc. Series A Stock Fundamentals & Key Indicators

Market Cap
$293.37M
PE Ratio (TTM)
-5.74
Dividend Yield
N/A
EPS (TTM)
$-1.58
Revenue (TTM)
N/A
Return On Equity (TTM)
-45.82%
Profit Margin
N/A
Debt to Equity
0.05
Quarterly Earnings Growth YoY
N/A

About Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Sagimet Biosciences Inc. Series A Historical Returns

MonthOpenCloseChange %
Aug 2026
$6.69
$9.07
+27.39%
Jul 2026
$7.88
$7.12
-7.89%
Jun 2026
$7.22
$7.73
+5.89%
May 2026
$8.17
$7.30
-9.54%
Apr 2026
$5.19
$8.07
+54.30%
Mar 2026
$5.64
$5.23
-8.57%
Feb 2026
$5.80
$5.72
+1.06%
Jan 2026
$5.94
$5.66
-4.39%
Dec 2025
$6.99
$5.92
-18.12%
Nov 2025
$8.55
$7.23
-15.09%
Oct 2025
$7.01
$8.52
+24.31%
Sep 2025
$7.38
$6.85
-8.42%

SGMT Share Price FAQs

What is Sagimet Biosciences Inc. Series A share price today?

chevron-up
Sagimet Biosciences Inc. Series A share price today is $9.07 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Sagimet Biosciences Inc. Series A stock?

chevron-up
The 52 week high of Sagimet Biosciences Inc. Series A stock is $10.03, while the 52 week low is $4.51 as of 8 Aug '26.

What is SGMT's market capitalisation today?

chevron-up
SGMT market capitalisation is $293.37M as of August 9, 2026, at 2:11 pm IST.

What is the 5 year returns of SGMT?

chevron-up
The 5 year returns of SGMT is -43.13% as on 8 Aug '26.

What is the high & low stock price of SGMT today?

chevron-up
SGMT stock price hit a high of $9.09 and low of $8.47 as of 8 Aug '26.

Can I buy SGMT shares in India?

chevron-up
Yes. You can buy SGMT in India by opening an international trading account.